Summary: Millions of Americans who have obesity could gain insurance coverage for drugs like Wegovy if the Trump administration allows the rule to go into effect.
Summary: Poseida is a public clinical-stage biopharmaceutical company which creates donor-derived CAR-T cell therapies
Summary: Standard venture-capital deal terms spark unusual legal fight between investor Alcon Research and its portfolio company Aurion Biotech
Summary: With Elevidys expansion in hand, Sarepta commits up to $10 billion to develop short interfering RNA–based drugs to build out its pipeline.
Summary: Currently, Eli Lilly’s GLP-1 drugs Mounjaro and Zepbound (tirzepatide) are not on the FDA’s shortage list but compounded pharmacies are still making them. That’s unprecedented.
